nodes	percent_of_prediction	percent_of_DWPC	metapath
Dolutegravir—POU2F2—Validated transcriptional targets of deltaNp63 isoforms—IL1A—ankylosing spondylitis	0.13	0.227	CbGpPWpGaD
Dolutegravir—POU2F2—BCR signaling pathway—CD79A—ankylosing spondylitis	0.12	0.208	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—RUNX3—ankylosing spondylitis	0.1	0.175	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—IL1RN—ankylosing spondylitis	0.0693	0.121	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—IL1A—ankylosing spondylitis	0.0499	0.0869	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—IL10—ankylosing spondylitis	0.0496	0.0864	CbGpPWpGaD
Dolutegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—ankylosing spondylitis	0.026	0.0454	CbGpPWpGaD
Dolutegravir—Opportunistic infection—Methylprednisolone—ankylosing spondylitis	0.023	0.054	CcSEcCtD
Dolutegravir—Opportunistic infection—Dexamethasone—ankylosing spondylitis	0.0209	0.0491	CcSEcCtD
Dolutegravir—Opportunistic infection—Betamethasone—ankylosing spondylitis	0.0209	0.0491	CcSEcCtD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—TNF—ankylosing spondylitis	0.0189	0.0329	CbGpPWpGaD
Dolutegravir—Opportunistic infection—Prednisone—ankylosing spondylitis	0.0182	0.0428	CcSEcCtD
Dolutegravir—Opportunistic infection—Methotrexate—ankylosing spondylitis	0.0152	0.0357	CcSEcCtD
Dolutegravir—Inflammation—Methylprednisolone—ankylosing spondylitis	0.00955	0.0224	CcSEcCtD
Dolutegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—ankylosing spondylitis	0.00725	0.0126	CbGpPWpGaD
Dolutegravir—Inflammation—Methotrexate—ankylosing spondylitis	0.00632	0.0148	CcSEcCtD
Dolutegravir—Alanine aminotransferase increased—Methylprednisolone—ankylosing spondylitis	0.00593	0.0139	CcSEcCtD
Dolutegravir—Hyperglycaemia—Dexamethasone—ankylosing spondylitis	0.00477	0.0112	CcSEcCtD
Dolutegravir—Hyperglycaemia—Betamethasone—ankylosing spondylitis	0.00477	0.0112	CcSEcCtD
Dolutegravir—Alanine aminotransferase increased—Prednisone—ankylosing spondylitis	0.0047	0.011	CcSEcCtD
Dolutegravir—Neutropenia—Prednisone—ankylosing spondylitis	0.0043	0.0101	CcSEcCtD
Dolutegravir—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.0042	0.00986	CcSEcCtD
Dolutegravir—Hyperglycaemia—Prednisone—ankylosing spondylitis	0.00415	0.00975	CcSEcCtD
Dolutegravir—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.00408	0.00957	CcSEcCtD
Dolutegravir—Vertigo—Prednisolone—ankylosing spondylitis	0.00397	0.00931	CcSEcCtD
Dolutegravir—Abdominal discomfort—Methotrexate—ankylosing spondylitis	0.00369	0.00866	CcSEcCtD
Dolutegravir—Vertigo—Triamcinolone—ankylosing spondylitis	0.00365	0.00856	CcSEcCtD
Dolutegravir—Vertigo—Methylprednisolone—ankylosing spondylitis	0.00364	0.00854	CcSEcCtD
Dolutegravir—Neutropenia—Methotrexate—ankylosing spondylitis	0.0036	0.00844	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00342	0.00804	CcSEcCtD
Dolutegravir—Renal failure—Methotrexate—ankylosing spondylitis	0.00337	0.00791	CcSEcCtD
Dolutegravir—Immune system disorder—Prednisone—ankylosing spondylitis	0.00333	0.00781	CcSEcCtD
Dolutegravir—Vertigo—Dexamethasone—ankylosing spondylitis	0.00331	0.00777	CcSEcCtD
Dolutegravir—Vertigo—Betamethasone—ankylosing spondylitis	0.00331	0.00777	CcSEcCtD
Dolutegravir—Insomnia—Prednisolone—ankylosing spondylitis	0.00326	0.00765	CcSEcCtD
Dolutegravir—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.00324	0.00761	CcSEcCtD
Dolutegravir—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00324	0.00761	CcSEcCtD
Dolutegravir—Mental disorder—Prednisone—ankylosing spondylitis	0.00323	0.00758	CcSEcCtD
Dolutegravir—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00321	0.00754	CcSEcCtD
Dolutegravir—Hepatitis—Methotrexate—ankylosing spondylitis	0.00308	0.00723	CcSEcCtD
Dolutegravir—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.00304	0.00714	CcSEcCtD
Dolutegravir—Urethral disorder—Methotrexate—ankylosing spondylitis	0.00302	0.00709	CcSEcCtD
Dolutegravir—Insomnia—Triamcinolone—ankylosing spondylitis	0.003	0.00703	CcSEcCtD
Dolutegravir—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00299	0.00702	CcSEcCtD
Dolutegravir—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00295	0.00692	CcSEcCtD
Dolutegravir—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00295	0.00692	CcSEcCtD
Dolutegravir—Vertigo—Prednisone—ankylosing spondylitis	0.00288	0.00676	CcSEcCtD
Dolutegravir—Fatigue—Triamcinolone—ankylosing spondylitis	0.00286	0.0067	CcSEcCtD
Dolutegravir—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00285	0.00669	CcSEcCtD
Dolutegravir—Immune system disorder—Methotrexate—ankylosing spondylitis	0.00278	0.00653	CcSEcCtD
Dolutegravir—Insomnia—Dexamethasone—ankylosing spondylitis	0.00272	0.00638	CcSEcCtD
Dolutegravir—Insomnia—Betamethasone—ankylosing spondylitis	0.00272	0.00638	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00271	0.00637	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.0027	0.00634	CcSEcCtD
Dolutegravir—Mental disorder—Methotrexate—ankylosing spondylitis	0.0027	0.00633	CcSEcCtD
Dolutegravir—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00265	0.00623	CcSEcCtD
Dolutegravir—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00261	0.00613	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00259	0.00609	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00259	0.00609	CcSEcCtD
Dolutegravir—Fatigue—Betamethasone—ankylosing spondylitis	0.00259	0.00608	CcSEcCtD
Dolutegravir—Fatigue—Dexamethasone—ankylosing spondylitis	0.00259	0.00608	CcSEcCtD
Dolutegravir—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00257	0.00603	CcSEcCtD
Dolutegravir—Skin disorder—Prednisone—ankylosing spondylitis	0.00254	0.00597	CcSEcCtD
Dolutegravir—UGT1A1—Metabolism—B3GNT2—ankylosing spondylitis	0.00247	0.0043	CbGpPWpGaD
Dolutegravir—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00246	0.00577	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00246	0.00577	CcSEcCtD
Dolutegravir—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00244	0.00573	CcSEcCtD
Dolutegravir—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00244	0.00572	CcSEcCtD
Dolutegravir—Vertigo—Methotrexate—ankylosing spondylitis	0.00241	0.00565	CcSEcCtD
Dolutegravir—Dizziness—Prednisolone—ankylosing spondylitis	0.00238	0.00559	CcSEcCtD
Dolutegravir—Asthenia—Triamcinolone—ankylosing spondylitis	0.00238	0.00558	CcSEcCtD
Dolutegravir—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00238	0.00558	CcSEcCtD
Dolutegravir—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00238	0.00558	CcSEcCtD
Dolutegravir—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00237	0.00557	CcSEcCtD
Dolutegravir—Insomnia—Prednisone—ankylosing spondylitis	0.00237	0.00556	CcSEcCtD
Dolutegravir—Pruritus—Triamcinolone—ankylosing spondylitis	0.00234	0.0055	CcSEcCtD
Dolutegravir—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00234	0.00549	CcSEcCtD
Dolutegravir—Rash—Prednisolone—ankylosing spondylitis	0.00227	0.00533	CcSEcCtD
Dolutegravir—Dermatitis—Prednisolone—ankylosing spondylitis	0.00227	0.00533	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.00227	0.00532	CcSEcCtD
Dolutegravir—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00226	0.00531	CcSEcCtD
Dolutegravir—Fatigue—Prednisone—ankylosing spondylitis	0.00226	0.0053	CcSEcCtD
Dolutegravir—Headache—Prednisolone—ankylosing spondylitis	0.00226	0.0053	CcSEcCtD
Dolutegravir—Dizziness—Triamcinolone—ankylosing spondylitis	0.00219	0.00514	CcSEcCtD
Dolutegravir—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00219	0.00513	CcSEcCtD
Dolutegravir—Asthenia—Betamethasone—ankylosing spondylitis	0.00216	0.00506	CcSEcCtD
Dolutegravir—Asthenia—Dexamethasone—ankylosing spondylitis	0.00216	0.00506	CcSEcCtD
Dolutegravir—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.00215	0.00504	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00214	0.00502	CcSEcCtD
Dolutegravir—Nausea—Prednisolone—ankylosing spondylitis	0.00214	0.00502	CcSEcCtD
Dolutegravir—Pruritus—Betamethasone—ankylosing spondylitis	0.00213	0.00499	CcSEcCtD
Dolutegravir—Pruritus—Dexamethasone—ankylosing spondylitis	0.00213	0.00499	CcSEcCtD
Dolutegravir—Skin disorder—Methotrexate—ankylosing spondylitis	0.00212	0.00499	CcSEcCtD
Dolutegravir—Vomiting—Triamcinolone—ankylosing spondylitis	0.00211	0.00494	CcSEcCtD
Dolutegravir—Vomiting—Methylprednisolone—ankylosing spondylitis	0.0021	0.00493	CcSEcCtD
Dolutegravir—Rash—Triamcinolone—ankylosing spondylitis	0.00209	0.0049	CcSEcCtD
Dolutegravir—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00209	0.0049	CcSEcCtD
Dolutegravir—Rash—Methylprednisolone—ankylosing spondylitis	0.00208	0.00489	CcSEcCtD
Dolutegravir—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00208	0.00489	CcSEcCtD
Dolutegravir—Headache—Triamcinolone—ankylosing spondylitis	0.00208	0.00487	CcSEcCtD
Dolutegravir—Headache—Methylprednisolone—ankylosing spondylitis	0.00207	0.00486	CcSEcCtD
Dolutegravir—Abdominal pain—Prednisone—ankylosing spondylitis	0.00207	0.00486	CcSEcCtD
Dolutegravir—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00206	0.00483	CcSEcCtD
Dolutegravir—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00206	0.00483	CcSEcCtD
Dolutegravir—Dizziness—Dexamethasone—ankylosing spondylitis	0.00199	0.00467	CcSEcCtD
Dolutegravir—Dizziness—Betamethasone—ankylosing spondylitis	0.00199	0.00467	CcSEcCtD
Dolutegravir—Insomnia—Methotrexate—ankylosing spondylitis	0.00198	0.00464	CcSEcCtD
Dolutegravir—Nausea—Triamcinolone—ankylosing spondylitis	0.00197	0.00462	CcSEcCtD
Dolutegravir—Nausea—Methylprednisolone—ankylosing spondylitis	0.00196	0.00461	CcSEcCtD
Dolutegravir—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00193	0.00453	CcSEcCtD
Dolutegravir—Vomiting—Dexamethasone—ankylosing spondylitis	0.00191	0.00449	CcSEcCtD
Dolutegravir—Vomiting—Betamethasone—ankylosing spondylitis	0.00191	0.00449	CcSEcCtD
Dolutegravir—Rash—Dexamethasone—ankylosing spondylitis	0.0019	0.00445	CcSEcCtD
Dolutegravir—Rash—Betamethasone—ankylosing spondylitis	0.0019	0.00445	CcSEcCtD
Dolutegravir—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00189	0.00444	CcSEcCtD
Dolutegravir—Dermatitis—Betamethasone—ankylosing spondylitis	0.00189	0.00444	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.00189	0.00443	CcSEcCtD
Dolutegravir—Fatigue—Methotrexate—ankylosing spondylitis	0.00189	0.00443	CcSEcCtD
Dolutegravir—Headache—Betamethasone—ankylosing spondylitis	0.00188	0.00442	CcSEcCtD
Dolutegravir—Headache—Dexamethasone—ankylosing spondylitis	0.00188	0.00442	CcSEcCtD
Dolutegravir—Asthenia—Prednisone—ankylosing spondylitis	0.00188	0.00441	CcSEcCtD
Dolutegravir—Pruritus—Prednisone—ankylosing spondylitis	0.00185	0.00435	CcSEcCtD
Dolutegravir—Diarrhoea—Prednisone—ankylosing spondylitis	0.00179	0.0042	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00179	0.0042	CcSEcCtD
Dolutegravir—Nausea—Betamethasone—ankylosing spondylitis	0.00179	0.00419	CcSEcCtD
Dolutegravir—Nausea—Dexamethasone—ankylosing spondylitis	0.00179	0.00419	CcSEcCtD
Dolutegravir—Dizziness—Prednisone—ankylosing spondylitis	0.00173	0.00406	CcSEcCtD
Dolutegravir—Abdominal pain—Methotrexate—ankylosing spondylitis	0.00173	0.00406	CcSEcCtD
Dolutegravir—Vomiting—Prednisone—ankylosing spondylitis	0.00166	0.00391	CcSEcCtD
Dolutegravir—Rash—Prednisone—ankylosing spondylitis	0.00165	0.00387	CcSEcCtD
Dolutegravir—Dermatitis—Prednisone—ankylosing spondylitis	0.00165	0.00387	CcSEcCtD
Dolutegravir—Headache—Prednisone—ankylosing spondylitis	0.00164	0.00385	CcSEcCtD
Dolutegravir—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.00161	0.00378	CcSEcCtD
Dolutegravir—Asthenia—Methotrexate—ankylosing spondylitis	0.00157	0.00368	CcSEcCtD
Dolutegravir—Nausea—Prednisone—ankylosing spondylitis	0.00155	0.00365	CcSEcCtD
Dolutegravir—Pruritus—Methotrexate—ankylosing spondylitis	0.00155	0.00363	CcSEcCtD
Dolutegravir—Diarrhoea—Methotrexate—ankylosing spondylitis	0.0015	0.00351	CcSEcCtD
Dolutegravir—Dizziness—Methotrexate—ankylosing spondylitis	0.00145	0.0034	CcSEcCtD
Dolutegravir—Vomiting—Methotrexate—ankylosing spondylitis	0.00139	0.00326	CcSEcCtD
Dolutegravir—Rash—Methotrexate—ankylosing spondylitis	0.00138	0.00324	CcSEcCtD
Dolutegravir—Dermatitis—Methotrexate—ankylosing spondylitis	0.00138	0.00323	CcSEcCtD
Dolutegravir—Headache—Methotrexate—ankylosing spondylitis	0.00137	0.00322	CcSEcCtD
Dolutegravir—Nausea—Methotrexate—ankylosing spondylitis	0.0013	0.00305	CcSEcCtD
